Clinical Trial Update: Effects of Body Mass Index on the Hyperemic Response to Regadenoson [NA]

View source ↗

Summary

A completed clinical trial update examining how body mass index influences the hyperemic blood flow response to regadenoson in individuals with obesity and endo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Obesity

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: University of Utah | Conditions: Obesity, Endothelial Dysfunction | NA | Status: COMPLETED | Results posted: 2011-05-24